The Future of HIV Treatment
GAMMORA, developed by Code Pharma, prevents virus production by rapidly eliminating HIV-infected cells through controlled cell death and replacing them with healthy CD4 cells, as shown in clinical studies.
The treatment works by inserting a lab-produced harmless peptide that allows viral DNA fragments to integrate excessively. This causes infected cells to self-destruct while leaving healthy cells unaffected.
Clinical Efficacy
Clinical studies demonstrate a clear reduction in latent HIV-infected cells and show Gammora’s ability to prevent virus production by rapidly eliminating infected cells through controlled cell death.
Gammora treatment has shown no unpleasant side effects, as its mechanism specifically targets HIV-infected cells while leaving healthy cells unscathed.
Eliminating HIV infected cells leaving healthy cells unscathed.
The Mechanism
Gammora is a synthetic 16-amino-acid peptide derived from the HIV-1 integrase, first identified at the Hebrew University in Israel. This lab-produced peptide short-circuits a mechanism that normally prevents further penetration of viral DNA fragments, causing infected cells to self-destruct through apoptosis while leaving healthy cells unaffected. Unlike antiretrovirals that delay HIV DNA integration, Gammora eliminates HIV-infected cells and progressively replaces them with healthy CD4 cells, potentially leading to an AIDS cure rather than just managing it as a chronic illness.
Latest News & Media
Code Pharma’s Gammora Shows Breakthrough Potential in HIV Treatment | BusinessWire
As published by BusinessWire, Code Pharma has announced promising eight-week results for its HIV drug, Gammora, hinting at a possible cure at the cellular level.
Code Pharma’s Gammora Shows Promising Results Toward a Potential HIV Cure | Yahoo Finance
As published on Yahoo Finance, Code Pharma announced encouraging results from an eight-week study of Gammora, a drug targeting human immunodeficiency virus (HIV), revealing potential
GAMMORA will be Featured at International Scientific Conferences
As recently published on Pressat, Gammora, an innovative HIV treatment developed by Code Pharma, is set to present groundbreaking findings from its clinical trials at